December 22, 2024

Acino integrates with Pharmax Pharmaceuticals boosting the portfolio in ME

Facebook
Twitter
LinkedIn
Aesch Farbe

Acino, a Swiss pharmaceutical company headquartered in Zurich, recently announced the integration of Pharmax Pharmaceuticals, a UAE-based manufacturer and distributor of high-quality medications. Both companies are owned by ADQ, an Abu Dhabi-based investment and holding company.

With the integration of Pharmax, Acino will add over 100 employees and a GCC and EU GMP-certified manufacturing site, complementing its operational capabilities and expanding its growing international footprint. Equipped to manufacture various dosage forms, including tablets, capsules, inhalers, injectables, and topicals, the newly added facility adheres to the high-quality standards set by the regulatory authorities in the UAE and Europe.

Sunil Bhilotra, Managing Director and interim CEO of Acino

Sunil Bhilotra, Managing Director and interim CEO of Acino stated “The integration of Pharmax Pharmaceuticals into Acino will accelerate our efforts towards becoming a leading provider of high-quality pharmaceuticals in the Middle East and beyond. We will advance our ability to distribute high-quality medicines to markets across the globe and achieve even greater levels of growth and innovation across the pharma value chain.”

Andrew Bird, Head of Region, Middle East, Turkey, and Africa, at Acino

“With this change, we are positioning ourselves at the forefront of the rapidly expanding pharmaceutical market in the UAE,” said Andrew Bird, Head of Region, Middle East, Turkey, and Africa, at Acino. “Our combined expertise alongside the support of ADQ will enable us to contribute to the UAE’s efforts of becoming a leading pharmaceutical hub and tap into the great potential of the region.”

Madhukar Tanna, CEO of Pharmax

“Our industry is continuously evolving, and this step will help both organizations deliver continued value to our patients and customers,” said Madhukar Tanna, CEO of Pharmax. “By integrating our workforce, products, and operations, we are building a stronger platform for the future.”

Aesch (Farbe) Pharmaceutical Market

According to the whitepaper by ADQ, the UAE’s pharmaceutical market is expected to grow by 27 percent between 2021 and 2025, reaching a value of $4.7 billion. The number of manufacturing units in the country reached 23 in 2021, up from four in 2010, with 14 producing medicines, four manufacturing medical devices, and two focused on disinfectant solutions. There are now more than 2,500 medicines produced locally.

The combined company will be able to leverage synergies across main therapeutic areas and share best practices, advancing product development capabilities and further strengthening Acino’s robust commercial performance.

Press Release received on Mail

Also on Acino:

Acino’s digital series raises awareness on Cardiovascular diseases

Acino and Pharmax collaborate to align with UAE’s strategy to become a regional pharmaceutical manufacturing hub

Share.

RELATED POSTS

Bob Kibbe appointed CEO of Tranzonic Companies and Hospeco Brands Group 2
Bob Kibbe Appointed CEO of Tranzonic and Hospeco Brands Group
Madinet Masr and ASEC Automation signs MoU. Image Courtesy: Madinet Masr
Madinet Masr Forges Partnership with ASEC Automation To Develop Investment
Seef Properties and Raedat signing ceremony, which was held at Seef headquarters. Image Courtesy: Seef Properties
Seef Properties Signs MoU With Female Entrepreneur Empowerment Platform, Ra’edat
  • Asialink Finance

LATEST POSTS

International Business Magazine
Charabanc Transportation officially introduces “Ankai”, the prestigious Chinese bus brand under Anhui Ankai Automobile Company Limited, in the UAE. This launch marks a significant step to enhance the nation’s transportation sector. Image Courtesy: Charabanc Transportation
Modon Holding completes the acquisition of La Zagaleta. Image Courtesy: Modon
Jyothi Bathula. Image Courtesy Mashreq